MARKET

PLX

PLX

Protalix Biother
AMEX
2.520
-0.170
-6.32%
After Hours: 2.510 -0.01 -0.39% 17:58 02/18 EST
OPEN
2.650
PREV CLOSE
2.690
HIGH
2.650
LOW
2.510
VOLUME
979.30K
TURNOVER
--
52 WEEK HIGH
2.760
52 WEEK LOW
0.8214
MARKET CAP
185.56M
P/E (TTM)
-18.4751
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PLX last week (0210-0214)?
Weekly Report · 1d ago
Weekly Report: what happened at PLX last week (0203-0207)?
Weekly Report · 02/10 11:19
Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference
PR Newswire · 02/04 11:50
Protalix BioTherapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 02/03 12:01
Protalix BioTherapeutics Price Target Raised to $15.00/Share From $10.00 by HC Wainwright & Co.
Dow Jones · 02/03 12:01
HC Wainwright & Co. Maintains Buy on Protalix BioTherapeutics, Raises Price Target to $15
Benzinga · 02/03 11:51
Analysts Offer Insights on Healthcare Companies: Evaxion Biotech (EVAX) and Protalix (PLX)
TipRanks · 02/03 11:31
Weekly Report: what happened at PLX last week (0127-0131)?
Weekly Report · 02/03 11:24
More
About PLX
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of severe gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its product, Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase)- a chemically modified enzyme under development for the potential treatment of severe gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate.

Webull offers Protalix Biotherapeutics Inc stock information, including AMEX: PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.